Photo: Quartz
SII Awaits Govt Approval To Conduct Trials Of Novavax COVID Vaccine
The Serum Institute of India has applied to the Drugs Controller General of India seeking permission to conduct domestic trials of ‘Novavax’ coronavirus vaccine. Reportedly, the US-based company claimed that Novavax showed 89.3% and 60% effectiveness during the trials in the UK and Africa respectively. Earlier, Novavax and SII collaborated to produce 2 billion vaccine doses. Besides, Novavax has received around $388 million from the Coalition… read-more
Tags: Novavax, SII, Serum Institute of India, DCGI
Courtesy: Live Mint
Photo: Anandabazar
COVID-19: India Clears Emergency Use Of 'Covaxin' And 'Covishield'
Ending the wait for COVID-19 vaccine, VG Somani, the Drug Controller General of India, on January 3 granted emergency-use approval to 'Covaxin' and 'Covishield'. Assuring people about the efficacy, Somani said, “We'll never approve anything if there is slightest of safety concern.” Moreover, the DCGI approved the vaccines for their "restricted use" based on the data submitted by Bharat Biotech and the Serum Institute of India. PM Narendra… read-more
Tags: Coronavirus, Covaxin, COVISHIELD, Coronavirus Vaccines, DCGI, PM Narendra Modi
Courtesy: NDTV
Photo: The Financial Express
Pfizer Asks DCGI's Approval For Vaccine Distribution In India
As per reports, Drugs Controller General of India (DCGI) has received a request from the US-based Pfizer for Emergency Use Authorization of the COVID-19 vaccine. In its application, Pfizer has asked for permission to import, sell and distribute the vaccine immediately without clinical trials on Indian population under New Drugs and Clinical Trials Rules, 2019. Earlier… read-more
Tags: Pfizer, DCGI, India, Covid-19 Vaccine
Courtesy: Livemint
